Rare diseases
Investigational molecules
Locations
Study of Relatlimab, Nivolumab, and Drug Combination for Patients with Advanced Cancer
FranceStudy of BMS-986253 with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors
BelgiumStudy of Chemotherapy and Nivolumab Before and After Surgery for Patients with Non-Small Cell Lung Cancer in the Upper Lung Area
SpainStudy of DF6002 alone and combined with nivolumab in patients with advanced solid tumors: A safety and effectiveness trial
FranceStudy Comparing Nivolumab, Nivolumab with Ipilimumab, or Chemotherapy for Patients with Metastatic Colorectal Cancer with High Microsatellite Instability
AustriaStudy Comparing Nivolumab and Cabozantinib with Sunitinib for Patients with Untreated Advanced Kidney Cancer
CzechiaStudy Comparing Relatlimab and Nivolumab Combination vs. Nivolumab Alone for Patients with Advanced Melanoma
AustriaStudy of nivolumab, relatlimab and bevacizumab combination for patients with untreated advanced or metastatic liver cancer (hepatocellular carcinoma)
FranceStudy of BT5528 alone and with nivolumab in patients with advanced solid tumors that have EphA2 protein expression
BelgiumStudy of Zolbetuximab Alone and with Drug Combination for Patients with Advanced Stomach or Gastroesophageal Junction Cancer
FranceStudy on the Safety and Effects of ATL001 and Nivolumab for Adults with Metastatic or Recurrent Melanoma
SpainStudy of Relatlimab and Nivolumab with Chemotherapy for Patients with Stage IV or Recurrent Non-Small Cell Lung Cancer
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
